Next Article in Journal
Leflunomide Applicability in Rheumatoid Arthritis: Drug Delivery Challenges and Emerging Formulation Strategies
Previous Article in Journal
Simulation of Plasma Level Changes in Cerivastatin and Its Metabolites, Particularly Cerivastatin Lactone, Induced by Coadministration with CYP2C8 Inhibitor Gemfibrozil, CYP3A4 Inhibitor Itraconazole, or Both, Using the Metabolite-Linked Model
 
 
Article

Article Versions Notes

Drugs Drug Candidates 2025, 4(3), 35; https://doi.org/10.3390/ddc4030035
Action Date Notes Link
article xml file uploaded 29 July 2025 11:35 CEST Original file -
article xml uploaded. 29 July 2025 11:35 CEST Update -
article pdf uploaded. 29 July 2025 11:35 CEST Version of Record https://www.mdpi.com/2813-2998/4/3/35/pdf-vor
article html file updated 29 July 2025 11:37 CEST Original file -
article xml file uploaded 30 July 2025 02:46 CEST Update -
article xml uploaded. 30 July 2025 02:46 CEST Update -
article pdf uploaded. 30 July 2025 02:46 CEST Updated version of record https://www.mdpi.com/2813-2998/4/3/35/pdf-vor
article html file updated 30 July 2025 02:48 CEST Update -
article xml file uploaded 30 July 2025 03:58 CEST Update -
article xml uploaded. 30 July 2025 03:58 CEST Update https://www.mdpi.com/2813-2998/4/3/35/xml
article pdf uploaded. 30 July 2025 03:58 CEST Updated version of record https://www.mdpi.com/2813-2998/4/3/35/pdf
article html file updated 30 July 2025 03:59 CEST Update https://www.mdpi.com/2813-2998/4/3/35/html
Back to TopTop